What Do We Know About Alk Outside of Lung Cancer?

The EML4 is the most frequently observed fusion partner but there are other fusion partners which are less common. There do seem to be some differences associated with the variants in terms of comes particularly with sort of with chryzotni maybe less so with the later generation alkinhibitors. I'm not sure that these variants at this point I don't think they really influence clinical practice in terms of which drug you use in which context. So lunch what about alk outside of lung cancer? I feel like every now and then I've seen cases and I Think I've even seen reports of response to alk and I think it might have been lymphoma. We have BRAF now with a